Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.

Saved in:
Bibliographic Details
Title: Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.
Authors: Pollack IF; Department of Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. ian.pollack@chp.edu.; Department of Neurosurgery, Children's Hospital of Pittsburgh, University of Pittsburgh, 4401, Penn Avenue, Pittsburgh, PA, 15224, USA. ian.pollack@chp.edu.; University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. ian.pollack@chp.edu., Jakacki RI; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Butterfield LH; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Hamilton RL; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Panigrahy A; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Normolle DP; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA., Connelly AK; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Dibridge S; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Mason G; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Whiteside TL; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Okada H; Department of Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Neurosurgery, University of California, San Francisco, CA, USA.
Source: Journal of neuro-oncology [J Neurooncol] 2016 Dec; Vol. 130 (3), pp. 517-527. Date of Electronic Publication: 2016 Sep 13.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7373
DOI:10.1007/s11060-016-2245-3